about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma...
Read More
1.58
-0.02
(-1.25%)
42,515
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..